Takatsuki, Japan

Wataru Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Rational Drug Design Laboratories. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wataru Watanabe. Retrieved from https://idiyas.com/inventor/wataru-watanabe-jq4b3u3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wataru Watanabe: A Pioneer in Antiviral Innovation

Introduction

Wataru Watanabe is an accomplished inventor based in Takatsuki, Japan. He is recognized for his significant contributions to the field of antiviral agents, with a focus on innovative compounds that hold the potential to combat viral infections.

Latest Patents

Watanabe holds one patent titled "Antiviral agent containing benzodithiin derivative as active ingredient." This patent highlights his innovative approach to addressing viral diseases through unique chemical compounds.

Career Highlights

Wataru Watanabe has built his career at Rational Drug Design Laboratories, where he applies his expertise in drug innovation and development. His work is pivotal in advancing the research community's understanding of antiviral therapies.

Collaborations

Throughout his career, Watanabe has collaborated with other talented individuals, including his coworkers Tsuyoshi Kajiyashiki and Ryu Sato. These collaborations have fostered an environment of shared knowledge and innovation, enhancing the impact of their research efforts.

Conclusion

Wataru Watanabe's dedication to developing antiviral agents showcases the importance of innovative thinking in scientific research. His contributions, represented by his patent, continue to inspire advancements in the field, promoting health and well-being through effective antiviral solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…